1. Home
  2. CRVS vs VVR Comparison

CRVS vs VVR Comparison

Compare CRVS & VVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$14.37

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Invesco Senior Income Trust (DE)

VVR

Invesco Senior Income Trust (DE)

HOLD

Current Price

$3.17

Market Cap

475.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVS
VVR
Founded
2014
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
475.6M
IPO Year
2016
1998

Fundamental Metrics

Financial Performance
Metric
CRVS
VVR
Price
$14.37
$3.17
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$28.20
N/A
AVG Volume (30 Days)
1.1M
829.3K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
48.04
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.54
$3.03
52 Week High
$26.95
$3.83

Technical Indicators

Market Signals
Indicator
CRVS
VVR
Relative Strength Index (RSI) 44.32 54.09
Support Level $12.95 $3.03
Resistance Level $18.73 $3.33
Average True Range (ATR) 0.95 0.06
MACD 0.13 0.01
Stochastic Oscillator 55.56 70.73

Price Performance

Historical Comparison
CRVS
VVR

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About VVR Invesco Senior Income Trust (DE)

Invesco Senior Income Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide a high level of current income, consistent with the preservation of capital. The company invests in a portfolio of interests in floating or variable senior loans to corporations, partnerships, and other entities which operate in a variety of industries and geographic regions.

Share on Social Networks: